Ausaf Bari

Ausaf Bari is an Associate Professor in both Neurosurgery and Radiation Oncology at the David Geffen School of Medicine at UCLA. His work bridges the fields of neurosurgery, neuroscience, and neuromodulation, with a particular focus on developing innovative treatments for neurological and psychiatric disorders through deep brain stimulation and related technologies.

Dr. Bari's research primarily focuses on deep brain stimulation (DBS) and neuromodulation therapies for various conditions including chronic pain, essential tremor, Parkinson's disease, epilepsy, and psychiatric disorders. His work spans both clinical applications and fundamental neuroscience research, examining how brain circuitry relates to neurological function and dysfunction. His research integrates advanced neuroimaging techniques, electrophysiological recordings, and computational approaches to improve neuromodulation therapies.

Dr. Bari's publication record demonstrates a strong focus on improving targeting precision for deep brain stimulation procedures, understanding the neural mechanisms underlying pain perception and modulation, and expanding the applications of neuromodulation to new conditions. His recent work has particularly emphasized chronic pain treatment through subgenual cingulate cortex stimulation, as well as refining thalamic targets for movement disorders and epilepsy.

• Deep Brain Stimulation Targeting: Research on precise anatomical targeting for DBS procedures using advanced imaging and tractography
• Chronic Pain Mechanisms: Investigation of thalamic and cortical circuits involved in chronic pain perception
• Neuromodulation for Psychiatric Disorders: Exploration of DBS applications for treatment-resistant depression and other psychiatric conditions
• Advanced Neuroimaging: Development of connectivity-based approaches to understand brain circuitry relevant to neuromodulation

Dr. Bari has received research funding from the NIH, including the grant "Deep Brain Stimulation of the Subgenual Cingulate Cortex for the Treatment of Medically Refractory Chronic Low Back Pain" (NIH UH3NS113661, 2019-2024), where he serves as Principal Investigator. This work represents a pioneering effort to apply neuromodulation techniques to chronic pain conditions that have been traditionally difficult to treat.